Normunity

Normunity is focused on developing innovative immunotherapies for cancer treatment. Their unique approach centers on "immune normalization," aiming to restore the immune system's natural anti-cancer functions rather than directly targeting tumor cells. Using a discovery engine, they discover the points of immune disruption that happen when cancer is present and then use these as targets for their new class of “immune normalizers” to cure cancer. Normunity’s first program includes drugs that remove these barriers to normal immune function but the specific products have not been disclosed.

Jobs: